Clinical Trial 20571

Optimizing Cellular and Humoral Immunity to Pneumococcus by Vaccination with Pneumococcal 13-valent conjugate vaccine before and after CD19-targeted CAR T-cell Immunotherapy

Disease Site: Lymphoma, Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 90016

Disease Site: Other Hematopoietic

PI: Sandoval-Sus, Jose

Clinical Trial 22464

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: A Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)

Disease Site: Thyroid, Head & Neck, Mouth, lip, nasal cavity

PI: Agosto Salgado, Sarimar

Clinical Trial 22463

SPECT-CT Guided Elective Contralateral Neck Treatment (Select) For Patients With Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial.

Disease Site: Lip, Oral Cavity and Pharynx, Head & Neck, Mouth, lip, nasal cavity

PI: Danan, Deepa

Clinical Trial 22461

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies

Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia

PI: Nishihori, Taiga

Clinical Trial 22333

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia

PI: Komrokji, Rami

Clinical Trial 23303

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

Disease Site: Prostate

PI: Yamoah, Kosj

Clinical Trial 23101

Disease Site: Other Hematopoietic

PI: Fernandez, Hugo

Clinical Trial 22325

A Phase 1 Study of Irreversible Electroporation and Pembrolizumab Immunotherapy in Locally Advanced Pancreatic Cancer

Disease Site: Pancreas

PI: Malafa, Mokenge

Clinical Trial 22102

A Phase 1b, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants with Solid Tumors

Disease Site: Breast, Other Female Genital, Ovary

PI: Han, Heather

Clinical Trial 22562

A Multicenter, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Uncommon EGFR Mutations Only)

Disease Site: Lung, Non small cell lung cancer

PI: Gray, Jhanelle

Clinical Trial 23335

Disease Site: Multiple Myeloma

PI: Nguyen, Nina